100 related articles for article (PubMed ID: 36412461)
1. Single-cell analysis extracted CAFs-related genes to established online app to predict clinical outcome and radiotherapy prognosis of prostate cancer.
Lai C; Wu Z; Li Z; Huang X; Hu Z; Yu H; Yuan Z; Shi J; Hu J; Mulati Y; Liu C; Xu K
Clin Transl Oncol; 2024 May; 26(5):1240-1255. PubMed ID: 38070051
[TBL] [Abstract][Full Text] [Related]
2. Tumor immune contexture predicts recurrence after prostatectomy and efficacy of androgen deprivation and immunotherapy in prostate cancer.
Han S; Shi T; Liao Y; Chen D; Yang F; Wang M; Ma J; Li H; Xu Y; Zhu T; Chen W; Wang G; Han Y; Xu C; Wang W; Cai S; Zhang X; Xing N
J Transl Med; 2023 Mar; 21(1):194. PubMed ID: 36918939
[TBL] [Abstract][Full Text] [Related]
3. A seven-gene prognosis model to predict biochemical recurrence for prostate cancer based on the TCGA database.
He Y; Zhang J; Chen Z; Sun K; Wu X; Wu J; Sheng L
Front Surg; 2022; 9():923473. PubMed ID: 37255653
[TBL] [Abstract][Full Text] [Related]
4. Establishment of cancer-associated fibroblasts-related subtypes and prognostic index for prostate cancer through single-cell and bulk RNA transcriptome.
Qian Y; Feng D; Wang J; Wei W; Wei Q; Han P; Yang L
Sci Rep; 2023 Jun; 13(1):9016. PubMed ID: 37270661
[TBL] [Abstract][Full Text] [Related]
5. Novel gene signature for predicting biochemical recurrence-free survival of prostate cancer and PRAME modulates prostate cancer progression.
Kadeerhan G; Xue B; Wu X; Hu X; Tian J; Wang D
Am J Cancer Res; 2023; 13(7):2861-2877. PubMed ID: 37559989
[TBL] [Abstract][Full Text] [Related]
6. Senescence-associated secretory phenotype constructed detrimental and beneficial subtypes and prognostic index for prostate cancer patients undergoing radical prostatectomy.
Feng D; Wang J; Li D; Wu R; Wei W; Zhang C
Discov Oncol; 2023 Aug; 14(1):155. PubMed ID: 37624511
[TBL] [Abstract][Full Text] [Related]
7. Identification of senescence-related lncRNA prognostic index correlating with prognosis and radiosensitivity in prostate cancer patients.
Feng D; Li L; Shi X; Zhu W; Wang J; Wu R; Li D; Wei W; Han P
Aging (Albany NY); 2023 Sep; 15(18):9358-9376. PubMed ID: 37742230
[TBL] [Abstract][Full Text] [Related]
8.
Kim SH; Joung JY; Park WS; Park J; Lee JS; Park B; Hong D
World J Mens Health; 2023 Jul; 41(3):712-723. PubMed ID: 36792093
[TBL] [Abstract][Full Text] [Related]
9. Membrane tension-mediated stiff and soft tumor subtypes closely associated with prognosis for prostate cancer patients.
Feng D; Wang J; Shi X; Li D; Wei W; Han P
Eur J Med Res; 2023 May; 28(1):172. PubMed ID: 37179366
[TBL] [Abstract][Full Text] [Related]
10. A programmed cell death-related gene signature to predict prognosis and therapeutic responses in liver hepatocellular carcinoma.
Gu X; Pan J; Li Y; Feng L
Discov Oncol; 2024 Mar; 15(1):71. PubMed ID: 38466483
[TBL] [Abstract][Full Text] [Related]
11. A pan-cancer analysis of the oncogenic and immunological roles of apolipoprotein F (APOF) in human cancer.
Shi X; Feng D; Li D; Han P; Yang L; Wei W
Eur J Med Res; 2023 Jun; 28(1):190. PubMed ID: 37312170
[TBL] [Abstract][Full Text] [Related]
12. A Ferroptosis-Related Gene Prognostic Index Associated With Biochemical Recurrence and Radiation Resistance for Patients With Prostate Cancer Undergoing Radical Radiotherapy.
Feng D; Shi X; Xiong Q; Zhang F; Li D; Wei W; Yang L
Front Cell Dev Biol; 2022; 10():803766. PubMed ID: 35223835
[No Abstract] [Full Text] [Related]
13. A Gene Prognostic Index Associated With Epithelial-Mesenchymal Transition Predicting Biochemical Recurrence and Tumor Chemoresistance for Prostate Cancer.
Feng D; Shi X; Xiong Q; Zhang F; Li D; Yang L
Front Oncol; 2021; 11():805571. PubMed ID: 35096608
[TBL] [Abstract][Full Text] [Related]
14. A gene prognostic index from cellular senescence predicting metastasis and radioresistance for prostate cancer.
Feng D; Li D; Shi X; Xiong Q; Zhang F; Wei Q; Yang L
J Transl Med; 2022 Jun; 20(1):252. PubMed ID: 35658892
[TBL] [Abstract][Full Text] [Related]
15. Energy Metabolism-Related Gene Prognostic Index Predicts Biochemical Recurrence for Patients With Prostate Cancer Undergoing Radical Prostatectomy.
Feng D; Shi X; Zhang F; Xiong Q; Wei Q; Yang L
Front Immunol; 2022; 13():839362. PubMed ID: 35280985
[TBL] [Abstract][Full Text] [Related]
16. An autophagy-related gene prognostic index predicting biochemical recurrence, metastasis, and drug resistance for prostate cancer.
Zhu WZ; Feng DC; Xiong Q; Shi X; Zhang FC; Wei Q; Yang L
Asian J Androl; 2023; 25(2):208-216. PubMed ID: 36412461
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial Aldehyde Dehydrogenase 2 Represents a Potential Biomarker of Biochemical Recurrence in Prostate Cancer Patients.
Feng D; Zhu W; You J; Shi X; Han P; Wei W; Wei Q; Yang L
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144737
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]